Bay City Capital Fund IV, L.P.
CIK 1360243 · last filed 2021-12-07
Bay City Capital Fund IV, L.P. is a corporate insider who has filed 9 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for MDGL, was dated Dec 7, 2021. Across all open-market trades the lifetime net is −$3.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $896.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$896.61M
4
9
-$3.14M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MDGL | 10%+ Owner | 1,511,782 | $553.48 | $836.74M | -$13.17M | 2 | 2021-12-07 |
| MAPP | 10%+ Owner | 2,195,653 | $27.27 | $59.87M | -$5.37M | 2 | 2010-03-11 |
| ReShape Weightloss Inc. (ETRM) Delisted | 10%+ Owner | 441,566 | — | — | $13.63M | 3 | 2008-04-28 |
| PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | 10%+ Owner | 112,251 | — | — | $1.77M | 1 | 2007-08-31 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-12-07 | MDGL | Other (J) | −3,296,688 | $0 | EDGAR |
| 2020-08-19 | MDGL | Sell (S) | −120,000 | -$13.17M | EDGAR |
| 2010-03-30 | — | Buy (P) | — | $0 | |
| 2010-03-11 | MAPP | Sell (S) | −339,914 | -$5.37M | EDGAR |
| 2008-04-28 | ReShape Weightloss Inc. (ETRM) Delisted | Buy (P) | +200,000 | $900.0K | EDGAR |
| 2008-03-04 | ReShape Weightloss Inc. (ETRM) Delisted | Buy (P) | +84,000 | $727.4K | EDGAR |
| 2007-11-19 | ReShape Weightloss Inc. (ETRM) Delisted | Buy (P) | +1,500,000 | $12.00M | EDGAR |
| 2007-10-12 | MAPP | Mixed | +2,347,077 | $34.04M | EDGAR |
| 2007-08-31 | PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | Buy (P) | +299,876 | $1.77M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.